asprin and extended-release dipyridamole
Generic: asprin and extended-release dipyridamole
Labeler: glenmark pharmaceuticals inc., usaDrug Facts
Product Profile
Brand Name
asprin and extended-release dipyridamole
Generic Name
asprin and extended-release dipyridamole
Labeler
glenmark pharmaceuticals inc., usa
Dosage Form
CAPSULE
Routes
Active Ingredients
aspirin 25 mg/1, dipyridamole 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68462-405
Product ID
68462-405_d202f375-08c4-42da-bd96-2b62d7ebe7e8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210318
Listing Expiration
2027-12-31
Marketing Start
2019-05-24
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68462405
Hyphenated Format
68462-405
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
asprin and extended-release dipyridamole (source: ndc)
Generic Name
asprin and extended-release dipyridamole (source: ndc)
Application Number
ANDA210318 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/1
- 200 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (68462-405-30)
- 60 CAPSULE in 1 BOTTLE (68462-405-60)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d202f375-08c4-42da-bd96-2b62d7ebe7e8", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0368462405604"], "unii": ["R16CO5Y76E", "64ALC7F90C"], "rxcui": ["259081"], "spl_set_id": ["467d6ce3-bc05-4aa1-87cc-3214fd628d39"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68462-405-30)", "package_ndc": "68462-405-30", "marketing_start_date": "20190524"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (68462-405-60)", "package_ndc": "68462-405-60", "marketing_start_date": "20190524"}], "brand_name": "ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE", "product_id": "68462-405_d202f375-08c4-42da-bd96-2b62d7ebe7e8", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "68462-405", "generic_name": "ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE", "active_ingredients": [{"name": "ASPIRIN", "strength": "25 mg/1"}, {"name": "DIPYRIDAMOLE", "strength": "200 mg/1"}], "application_number": "ANDA210318", "marketing_category": "ANDA", "marketing_start_date": "20190524", "listing_expiration_date": "20271231"}